Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma
- S. Lee
- , Y. H. Park
- , K. H. Kim
- , E. Y. Cho
- , Y. C. Ahn
- , K. Kim
- , Y. M. Shim
- , J. S. Ahn
- , K. Park
- , Y. H. Im
- Sungkyunkwan University
Research output: Contribution to journal › Article › peer-review
22
Link opens in a new tab
Scopus
citations